Novaquin

RSS

meloxicam

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Novaquin. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Novaquin.

For practical information about using Novaquin, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 12/02/2016

Authorisation details

Product details
Name
Novaquin
Agency product number
EMEA/V/C/003866
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
Publication details
Marketing-authorisation holder
Le Vet Beheer B.V. 
Revision
1
Date of issue of marketing authorisation valid throughout the European Union
08/09/2015
Contact address
Le Vet Beheer B.V.
Wilgenweg 7
3421 TV Oudewater
The Netherlands

Product information

22/01/2016 Novaquin - EMEA/V/C/003866 - IAIN/0001

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Anti inflammatory and antirheumatic products
  • non steroids (oxicams)

Therapeutic indication

Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses.

Assessment history

How useful was this page?

Add your rating